RÉSUMÉ
The use of cinnamaldehyde and Vitamin C can improve immunity and intestinal health. A two-way factorial design was employed to investigate the main and interactive effects of cinnamaldehyde and vitamin C on the growth, carcass, and intestinal health of broiler chickens. A total of 288 one-day-old female Arbor Acres broiler chicks were randomly distributed among four treatment groups, consisting of six replicate cages with 12 birds each. Four treatments were basal diet or control (CON), supplemental cinnamaldehyde (CA) 300 g/ton (g/t), vitamin C (VC) 300 g/t, and cinnamaldehyde 300 g/t, and vitamin C 300 g/t (CA + VC), respectively. The results showed that supplemental CA did not affect the growth performance or slaughter performance of broilers at 21 days (d), 42 days (d), and 1-42 days (d); however, it could improve intestinal barrier function at 42 d of age and reduce the mRNA expression of inflammatory factors in the intestine at 21 d and 42 d of age. Supplemental VC showed a trend towards increasing body weight gain (BWG) at 21 d (p = 0.094), increased breast muscle rate (at 21-d 5.33%, p < 0.05 and at 42-d 7.09%, p = 0.097), and decreased the abdominal fat (23.43%, p < 0.05) and drip loss (20.68%, p < 0.05) at 42-d. Moreover, VC improves intestinal morphology and intestinal barrier function and maintains a balanced immune response. The blend of CA and VC significantly upregulated the mRNA expression of myeloid differentiation factor 88 (MyD-88) in the intestine at 21 d of age, the mRNA expression of catalase (CAT), Occludin, Claudin-1, Mucin-2, nuclear factor-kappa B (NF-κB) and toll-like receptor 4 (TLR-4) in the intestine at 42 d of age (p < 0.01), and downregulated the mRNA expression of interleukin 10 (IL-10), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) in the intestine at 21-d and 42-d of age, and interleukin-1 beta (IL-1ß) mRNA in intestine at 42 d of age (p < 0.01). This study suggested that the combination of CA and VC had the potential to regulate intestinal health and result in better carcass character of broilers.
Sujet(s)
Acroléine , Acide ascorbique , Poulets , Intestins , Animaux , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Acide ascorbique/pharmacologie , Intestins/effets des médicaments et des substances chimiques , Femelle , Compléments alimentaires , Aliment pour animaux , Muqueuse intestinale/métabolisme , Muqueuse intestinale/effets des médicaments et des substances chimiquesSujet(s)
Acroléine , Berbérine , Tumeurs du poumon , Tumeurs du poumon/prévention et contrôle , Tumeurs du poumon/traitement médicamenteux , Humains , Berbérine/pharmacologie , Berbérine/usage thérapeutique , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Animaux , Carcinogenèse/effets des médicaments et des substances chimiquesRÉSUMÉ
Free fatty acids have long been used as dietary supplements in aquaculture, but the application of monoglycerides has increased interest in more recent times. The study aimed to investigate the effects of dietary short- and medium-chain fatty acid monoglyceride and cinnamaldehyde (SMMG) on the growth performance, survival, immune responses, and tolerance to hypoxic stress of Pacific white shrimp (Litopenaeus vannamei). In Experiment 1, shrimp post-larvae were divided into 4 groups with 6 replicates and fed with diets supplemented with 0 (control), 0.3, 0.4, and 0.5% diet for 30 days. The final body weight and survival rate were determined. In Experiment 2, the juvenile shrimp from Experiment 1 were subjected to hypoxic stress conditions (dissolved oxygen level 2-2.5 mg/L) for 14 days, then the specific growth rate (SGR), survival rate, intestinal Vibrio spp. count, immune responses, and histopathological change of the hepatopancreas were analyzed. Following the 30-day feeding trial, the results revealed that the final body weight and survival of the 0.3-0.5% SMMG groups (2.81-3.06 g and 74.00-84.33%, respectively) were significantly higher than the control shrimp (1.96 g and 68.33%, respectively). In the hypoxic stress experiment, the survival rates of shrimp fed 0.4-0.5% SMMG (71.67-80.00%) were significantly higher than the control (51.67%). Although the SGR were not affected by SMMG supplementation, all immune parameters evaluated were significantly enhanced, and the intestinal Vibrio spp. counts were significantly decreased in the 0.4-0.5% SMMG-fed shrimp; the histopathological structure of the hepatopancreas was also improved in these shrimp compared to the control. Our findings indicated that SMMG as a feed additive has beneficial effects in improving shrimp health and increasing tolerance to hypoxic conditions.
Sujet(s)
Acroléine , Penaeidae , Stress physiologique , Animaux , Penaeidae/immunologie , Penaeidae/effets des médicaments et des substances chimiques , Penaeidae/croissance et développement , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Stress physiologique/effets des médicaments et des substances chimiques , Compléments alimentaires , Aquaculture/méthodes , Hépatopancréas/effets des médicaments et des substances chimiques , Hépatopancréas/immunologie , Hépatopancréas/anatomopathologie , Aliment pour animaux , Acides gras/métabolismeRÉSUMÉ
Cancer incidence is increasing globally, presenting a growing public health challenge. While anticancer drugs are crucial in treatment, their limitations, including poor targeting ability and high toxicity, hinder effectiveness and patient safety, requiring relentless scientific research and technological advancements to develop safer and more effective therapeutics. Cinnamaldehyde (CA), an active compound derived from the natural plant cinnamon, has garnered attention in pharmacological research due to its diverse therapeutic applications. CA has potential in treating a wide array of conditions, including cardiovascular diseases, diabetes, inflammatory disorders and various forms of cancer. The present review comprehensively summarizes the physicochemical and pharmacokinetic profiles of CA, and delves into the latest advancements in elucidating its potential mechanisms and targets across various cancer types. CA and its derivatives have antitumor effects, which encompass inhibiting cell proliferation, arresting the cell cycle, inducing apoptosis, limiting cell migration and invasion, and suppressing angiogenesis. Additionally, the present review explores targeted formulations of CA, laying a scientific foundation for further exploration of its implications in cancer prevention and treatment strategies.
Sujet(s)
Acroléine , Antinéoplasiques , Tumeurs , Acroléine/analogues et dérivés , Acroléine/composition chimique , Acroléine/pharmacologie , Acroléine/usage thérapeutique , Humains , Tumeurs/traitement médicamenteux , Tumeurs/métabolisme , Animaux , Antinéoplasiques/usage thérapeutique , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Antinéoplasiques/pharmacocinétique , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiquesRÉSUMÉ
Osteoarthritis (OA) is a degenerative joint disorder that is distinguished by inflammation and chronic cartilage damage. Interleukin-1ß (IL-1ß) is a proinflammatory cytokine that plays an important role in the catabolic processes that underlie the pathogenesis of OA. In this study, we investigate the therapeutic efficacy of exosomes derived from untreated bone-marrow-derived mesenchymal stem cells (BMMSC-Exo) and those treated with cinnamaldehyde (BMMSC-CA-Exo) for preventing the in vitro catabolic effects of IL-1ß on chondrocytes. We stimulated chondrocytes with IL-1ß to mimic the inflammatory microenvironment of OA. We then treated these chondrocytes with BMMSC-Exo and BMMSC-CA-Exo isolated via an aqueous two-phase system and evaluated their effects on the key cellular processes using molecular techniques. Our findings revealed that treatment with BMMSC-Exo reduces the catabolic effects of IL-1ß on chondrocytes and alleviates inflammation. However, further studies directly comparing treatments with BMMSC-Exo and BMMSC-CA-Exo are needed to determine if CA preconditioning can provide additional anti-inflammatory benefits to the exosomes beyond those of CA preconditioning or treatment with regular BMMSC-Exo. Through a comprehensive molecular analysis, we elucidated the regulatory mechanisms underlying this protective effect. We found a significant downregulation of proinflammatory signaling pathways in exosome-infected chondrocytes, suggesting the potential modulation of the NF-κB and MAPK signaling cascades. Furthermore, our study identified the molecular cargo of BMMSC-Exo and BMMSC-CA-Exo, determining the key molecules, such as anti-inflammatory cytokines and cartilage-associated factors, that may contribute to their acquisition of chondroprotective properties. In summary, BMMSC-Exo and BMMSC-CA-Exo exhibit the potential as therapeutic agents for OA by antagonizing the in vitro catabolic effects of IL-1ß on chondrocytes. The regulation of the proinflammatory signaling pathways and bioactive molecules delivered by the exosomes suggests a multifaceted mechanism of action. These findings highlight the need for further investigation into exosome-based therapies for OA and joint-related diseases.
Sujet(s)
Acroléine , Chondrocytes , Exosomes , Inflammation , Interleukine-1 bêta , Cellules souches mésenchymateuses , Transduction du signal , Exosomes/métabolisme , Interleukine-1 bêta/métabolisme , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Cellules souches mésenchymateuses/métabolisme , Cellules souches mésenchymateuses/effets des médicaments et des substances chimiques , Chondrocytes/métabolisme , Chondrocytes/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Inflammation/métabolisme , Animaux , Arthrose/métabolisme , Arthrose/traitement médicamenteux , Humains , Cellules cultivéesRÉSUMÉ
Oleum cinnamomi (OCM) is a volatile component of the Cinnamomum cassia Presl in the Lauraceae family, which displays broad-spectrum antibacterial properties. It has been found that OCM has a significant inhibitory effect against Cutibacterium acnes (C. acnes), but the precise target and molecular mechanism are still not fully understood. In this study, the antibacterial activity of OCM against C. acnes and its potential effect on cell membranes were elucidated. Metabolomics methods were used to reveal metabolic pathways, and proteomics was used to explore the targets of OCM inhibiting C. acnes. The yield of the OCM was 3.3% (w/w). A total of 19 compounds were identified, representing 96.213% of the total OCM composition, with the major constituents being phenylpropanoids (36.84%), sesquiterpenoids (26.32%), and monoterpenoids (15.79%). The main component identified was trans-cinnamaldehyde (85.308%). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of OCM on C. acnes were 60 µg/mL and 180 µg/mL, respectively. The modified proteomics results indicate that cinnamaldehyde was the main bioactive ingredient within OCM, which covalently modifies the ABC transporter adenosine triphosphate (ATP)-binding protein and nicotinamide adenine dinucleotide (NADH)-quinone oxidoreductase, hindering the amino acid transport process, and disrupting the balance between NADH and nicotinamide adenine dinucleoside phosphorus (NAD+), thereby hindering energy metabolism. We have reported for the first time that OCM exerts an antibacterial effect by covalent binding of cinnamaldehyde to target proteins, providing potential and interesting targets to explore new control strategies for gram-positive anaerobic bacteria.
Sujet(s)
Antibactériens , Antibactériens/pharmacologie , Antibactériens/composition chimique , Tests de sensibilité microbienne , Propionibacteriaceae/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Protéomique/méthodes , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Acroléine/composition chimique , Métabolomique/méthodesRÉSUMÉ
Dental caries is a chronic oral infectious disease, and Streptococcus mutans (S. mutans) plays an important role in the formation of dental caries. Trans-cinnamaldehyde (CA) exhibits broad-spectrum antibacterial activity; however, its target and mechanism of action of CA on S. mutans needs to be further explored. In this study, it was verified that CA could inhibit the growth and biofilm formation of S. mutans. Further proteomic analysis identified 33, 55, and 78 differentially expressed proteins (DEPs) in S. mutans treated with CA for 1, 2, and 4 h, respectively. Bioinformatics analysis showed that CA interfered with carbohydrate metabolism, glycolysis, pyruvate metabolism, and the TCA cycle, as well as amino acid metabolism of S. mutans. Protein interactions suggested that pyruvate dehydrogenase (PDH) plays an important role in the antibacterial effect of CA. Moreover, the upstream and downstream pathways related to PDH were verified by various assays, and the results proved that CA not only suppressed the glucose and sucrose consumption and inhibited glucosyltransferase (GTF) and lactate dehydrogenase (LDH) activities but also decreased the ATP production. Interestingly, the protein interaction, qRT-PCR, and molecular docking analysis showed that PDH might be the target of CA to fight S. mutans. In summary, the study shows that CA interferes with the carbohydrate metabolism of bacteria by inhibiting glycolysis and the tricarboxylic acid (TCA) cycle via binding to PDH, which verifies that PDH is a potential target for the development of new drugs against S. mutans.
Sujet(s)
Acroléine , Métabolisme glucidique , Simulation de docking moléculaire , Complexe du pyruvate déshydrogénase , Streptococcus mutans , Streptococcus mutans/effets des médicaments et des substances chimiques , Streptococcus mutans/génétique , Streptococcus mutans/enzymologie , Acroléine/pharmacologie , Acroléine/analogues et dérivés , Acroléine/métabolisme , Métabolisme glucidique/effets des médicaments et des substances chimiques , Complexe du pyruvate déshydrogénase/métabolisme , Complexe du pyruvate déshydrogénase/antagonistes et inhibiteurs , Antibactériens/pharmacologie , Glycolyse/effets des médicaments et des substances chimiques , Biofilms/effets des médicaments et des substances chimiques , Biofilms/croissance et développement , Protéines bactériennes/métabolisme , Protéines bactériennes/génétique , Protéines bactériennes/antagonistes et inhibiteurs , Protéomique/méthodes , Caries dentaires/microbiologie , Cycle citrique/effets des médicaments et des substances chimiques , Adénosine triphosphate/métabolismeRÉSUMÉ
Most of postharvest agricultural produces are perishable due to microorganisms infections and physiological change. Herein, one kind of multifunctional coating film of SC-ECCNPs was developed by incorporating organic nanoparticles of ECCNPs into starch/carboxymethylcellulose (SC) to prolong shelf life of food with excellent performances. The SC-ECCNPs coating was prepared with starch and sodium carboxymethylcellulose as film substrate (SC) to incorporate with organic nanoparticles of ECCNPs formed by integrating epigallocatechin-3-gallate (EGCG), cysteine (Cys), and cinnamaldehyde (CA). The incorporation of ECCNPs improves the UV-resistance and physical properties of SC-ECCNPs coating and also endows it with excellent antioxidative and broad-spectrum antibacterial activity. The application possibilities of SC-ECCNPs coating were explored with strawberries and oranges as samples, validating that the SC-ECCNPs coating can prolong the shelf life of fruits at room temperature. The biosafety of the coating was further confirmed with hemolysis and MTT experiments. The SC-ECCNPs coating film was prepared with natural substrates via a simple and green method. The investigation provides an instructive way for developing advanced packaging materials with high performances.
Sujet(s)
Antibactériens , Carboxyméthylcellulose de sodium , Nanoparticules , Amidon , Amidon/composition chimique , Carboxyméthylcellulose de sodium/composition chimique , Nanoparticules/composition chimique , Antibactériens/composition chimique , Antibactériens/pharmacologie , Antioxydants/composition chimique , Antioxydants/pharmacologie , Conservation aliments/méthodes , Emballage alimentaire/méthodes , Fruit/composition chimique , Acroléine/analogues et dérivés , Acroléine/composition chimiqueRÉSUMÉ
Objective: Trichomonas vaginalis is a sexually transmitted protozoan parasite that usually causes infections in women. Metronidazole is used as the first choice in the treatment of this parasitic disease, but there is a need for new drugs since 1980's with increasing numbers of reported resistance. In this study, it was aimed to determine the antitrichomonal activity of the major components of Cinnamomum zeylanicum (cinnamon) and Thymus vulgaris (thyme) essential oils, cinnamaldehyde, carvacrol and thymol against metronidazole resistant and susceptible T. vaginalis strains, and to determine their interaction with metronidazole by checkerboard method. Methods: Cinnamaldehyde, carvacrol, thymol and metronidazole were obtained commercially. Two clinical isolates and one metronidazole resistant T. vaginalis reference strain were used in the study. MIC50 and MLC values of essential oil components and metronidazole were determined by broth microdilution method. The combinations of essential oil components with metronidazole were determined by the checkerboard method. Results: According to in vitro activity tests, cinnamaldehyde was determined to be most effective essential oil component. Clinical isolates were susceptible to metronidazole. In combination study, metronidazole showed synergy with cinnamaldehyde and carvacrol, and partial synergy with thymol. Conclusion: It was determined that cinnamaldehyde, carvacrol and thymol, which are known to have high antimicrobial activity, also have strong activity against T. vaginalis isolates and show a synergistic interaction with metronidazole. The use of metronidazole at lower doses in the synergistic interaction may contribute to the literature in terms of reducing drug side effects, creating a versatile antimicrobial target, and reducing the rate of resistance development.
Sujet(s)
Acroléine , Cymènes , Synergie des médicaments , Métronidazole , Monoterpènes , Huile essentielle , Thymol , Thymus (plante) , Trichomonas vaginalis , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Thymol/pharmacologie , Cymènes/pharmacologie , Métronidazole/pharmacologie , Humains , Huile essentielle/pharmacologie , Thymus (plante)/composition chimique , Trichomonas vaginalis/effets des médicaments et des substances chimiques , Monoterpènes/pharmacologie , Femelle , Cinnamomum zeylanicum/composition chimique , Antiprotozoaires/pharmacologie , Tests de sensibilité microbienne , Résistance aux substancesRÉSUMÉ
Accumulation of advanced glycation end-products (AGEs) in the brain contributes significantly to cognitive impairment in patients with diabetes by disrupting the post-mitotic state of neuronal cells, thereby triggering ectopic cell cycle re-entry (CCR) and subsequent neuronal apoptosis. Cinnamaldehyde (CINA), a potential mitigator of cognitive impairment due to its blood glucose-lowering properties, warrants exploration for its role in counteracting diabetes-related neurological damage. In this study, we examined the neuroprotective effect of CINA on AGE-damaged SH-SY5Y human neuroblastoma cells differentiated in vitro. We investigated the impact of CINA on AGE-induced neuronal CCR and apoptosis, finding that it substantially suppressed aberrant DNA replication, precluded cells from entering the mitotic preparatory phase, and diminished apoptosis. Additionally, CINA inhibited the expression of eIF4E without altering S6K1 phosphorylation. These findings indicate that CINA safeguards neuronal cells from AGE-related damage by preventing abnormal CCR, preserving the post-mitotic state of neuronal cells, and reducing AGE-induced apoptosis, potentially through the inhibition of eIF4E-controlled cell proliferation. Our results highlight the prospective utility of CINA in managing diabetic neuropathy.
Sujet(s)
Acroléine , Apoptose , Cycle cellulaire , Produits terminaux de glycation avancée , Neurones , Neuroprotecteurs , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Humains , Produits terminaux de glycation avancée/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Neuroprotecteurs/pharmacologie , Cycle cellulaire/effets des médicaments et des substances chimiques , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Lignée cellulaire tumorale , Neuropathies diabétiques/prévention et contrôle , Neuropathies diabétiques/métabolisme , Neuropathies diabétiques/traitement médicamenteux , Réplication de l'ADN/effets des médicaments et des substances chimiques , Phosphorylation/effets des médicaments et des substances chimiquesRÉSUMÉ
Late blight, caused by the notorious pathogen Phytophthora infestans, poses a significant threat to potato (Solanum tuberosum) crops worldwide, impacting their quality as well as yield. Here, we aimed to investigate the potential use of cinnamaldehyde, carvacrol, and eugenol as control agents against P. infestans and to elucidate their underlying mechanisms of action. To determine the pathogen-inhibiting concentrations of these three plant essential oils (PEOs), a comprehensive evaluation of their effects using gradient dilution, mycelial growth rate, and spore germination methods was carried out. Cinnamaldehyde, carvacrol, and eugenol were capable of significantly inhibiting P. infestans by hindering its mycelial radial growth, zoospore release, and sporangium germination; the median effective inhibitory concentration of the three PEOs was 23.87, 8.66, and 89.65 µl/liter, respectively. Scanning electron microscopy revealed that PEOs caused the irreversible deformation of P. infestans, resulting in hyphal shrinkage, distortion, and breakage. Moreover, propidium iodide staining and extracellular conductivity measurements demonstrated that all three PEOs significantly impaired the integrity and permeability of the pathogen's cell membrane in a time- and dose-dependent manner. In vivo experiments confirmed the dose-dependent efficacy of PEOs in reducing the lesion diameter of potato late blight. Altogether, these findings provide valuable insight into the antifungal mechanisms of PEOs vis-à-vis late blight-causing P. infestans. By utilizing the inherent capabilities of these natural compounds, we could effectively limit the harmful impacts of late blight on potato crops, thereby enhancing agricultural practices and ensuring the resilience of global potato food production.
Sujet(s)
Cymènes , Eugénol , Huile essentielle , Phytophthora infestans , Maladies des plantes , Solanum tuberosum , Phytophthora infestans/effets des médicaments et des substances chimiques , Phytophthora infestans/physiologie , Solanum tuberosum/microbiologie , Huile essentielle/pharmacologie , Maladies des plantes/microbiologie , Maladies des plantes/prévention et contrôle , Eugénol/pharmacologie , Cymènes/pharmacologie , Monoterpènes/pharmacologie , Mycelium/effets des médicaments et des substances chimiques , Mycelium/croissance et développement , Huiles végétales/pharmacologie , Hyphae/effets des médicaments et des substances chimiques , Hyphae/croissance et développement , Spores/effets des médicaments et des substances chimiques , Spores/physiologie , Acroléine/analogues et dérivésRÉSUMÉ
OBJECTIVES: This study investigated the anti-cryptococcal potential of certain essential oils (EOs)/compounds alone and in combination with fluconazole. MATERIALS AND METHODS: We investigated the antifungal activity of oils of Cinnamomum verum, Cymbopogon citratus, Cymbopogon martini, and Syzygium aromaticum, and their major active ingredients cinnamaldehyde, citral, eugenol, and geraniol against clinical and standard strains of Cryptococcus neoformans (CN). Disc diffusion, broth microdilution, checkerboard methods, and transmission electron microscopy were employed to determine growth inhibition, synergistic interaction, and mechanism of action of test compounds. RESULTS: EOs/compounds showed pronounced antifungal efficacy against azole-resistant CN in the order of cinnamaldehyde > eugenol > S. aromaticum > C. verum > citral > C. citratus > geraniol ≥ C. martini, each exhibiting zone of inhibition >15 mm. These oils/compounds were highly cidal compared to fluconazole. Eugenol and cinnamaldehyde showed the strongest synergy with fluconazole against CN by lowering their MICs up to 32-fold. Transmission electron microscopy indicated damage of the fungal cell wall, cell membrane, and other endomembranous organelles. CONCLUSION: Test oils and their active compounds exhibited potential anti-cryptococcus activity against the azole-resistant strains of CN. Moreover, eugenol and cinnamaldehyde significantly potentiated the anti-cryptococcal activity of fluconazole. It is suggested that multiple sites of action from oils/compounds could turn static fluconazole into a cidal drug combination in combating cryptococcosis.
RésuméObjectifs: Cette étude a étudié le potentiel anti-cryptocoque de certaines huiles essentielles (HE)/composés seuls et en combinaison avec fluconazole. Matériels et méthodes: Nous avons étudié l'activité antifongique des huiles de Cinnamomum verum, Cymbopogon citratus, Cymbopogon martini et Syzygium spiceum , et leurs principaux ingrédients actifs, le cinnamaldéhyde, le citral, l'eugénol et le géraniol, contre les normes cliniques et standards. souches de Cryptococcus neoformans (CN). Diffusion sur disque, microdilution en bouillon, méthodes en damier et microscopie électronique à transmission ont été utilisés pour déterminer l'inhibition de la croissance, l'interaction synergique et le mécanisme d'action des composés testés. Résultats: HE/composés a montré une efficacité antifongique prononcée contre les CN résistantes aux azoles dans l'ordre suivant: cinnamaldéhyde > eugénol > S. spiceum > C. verum > citral > C. citratus > géraniol ≥ C. martini , chacun présentant une zone d'inhibition > 15 mm. Ces huiles/composés étaient hautement cides par rapport au fluconazole. L'eugénol et le cinnamaldéhyde ont montré la synergie la plus forte avec le fluconazole contre le CN en abaissant leurs CMI jusqu'à 32 fois. La microscopie électronique à transmission a indiqué des dommages à la paroi cellulaire fongique, à la membrane cellulaire et à d'autres organites endomembranaires. Conclusion: Les huiles testées et leurs composés actifs ont montré une activité anti-cryptocoque potentielle contre les souches de CN résistantes aux azoles. De plus, l'eugénol et le cinnamaldéhyde ont significativement potentialisé l'activité anticryptococcique du fluconazole. Il est suggéré que plusieurs Les sites d'action des huiles/composés pourraient transformer le fluconazole statique en une combinaison médicamenteuse cide pour lutter contre la cryptococcose.
Sujet(s)
Acroléine , Antifongiques , Cryptococcus neoformans , Cymbopogon , Résistance des champignons aux médicaments , Synergie des médicaments , Eugénol , Fluconazole , Tests de sensibilité microbienne , Huile essentielle , Cryptococcus neoformans/effets des médicaments et des substances chimiques , Cryptococcus neoformans/ultrastructure , Fluconazole/pharmacologie , Antifongiques/pharmacologie , Huile essentielle/pharmacologie , Cymbopogon/composition chimique , Résistance des champignons aux médicaments/effets des médicaments et des substances chimiques , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Eugénol/pharmacologie , Humains , Monoterpènes acycliques/pharmacologie , Syzygium/composition chimique , Cinnamomum zeylanicum/composition chimique , Terpènes/pharmacologie , Monoterpènes/pharmacologie , Microscopie électronique à transmission , Huiles végétales/pharmacologie , Cryptococcose/traitement médicamenteux , Cryptococcose/microbiologieRÉSUMÉ
OBJECTIVE: Atherosclerosis (AS) is a common pathogenesis of cardiovascular diseases. Puerarin (Pue) is a Chinese herbal remedy used to prevent and treat AS. Here, this research investigated the effect of Pue on AS progression. METHODS: ApoE-/- mice were induced with acrolein. Body weight, blood lipid index, inflammatory factors, mitochondrial oxidative stress, and lipid deposition were detected. IL-6 and TNF-α were detected by ELISA. Oil red staining and H&E staining were used to observe the aortic sinus plaque lesions. Serum expressions of inflammatory factors IL-6, TNF-a, SOD, GSH and MDA were detected by ELISA, the mRNA expression levels of HDAC1 in the aorta were detected by RT-qPCR, and IL-6 and TNF-α in the aorta were detected by immunohistochemistry. JNK, p-JNK, OPA-1, and HDAC1 were detected by Western blotting. RESULTS: Pue administration can effectively reduce lipid accumulation in AS mice induced by acrolein. Pue promoted the activity of SOD, GSH and MDA, and inhibited the formation of atherosclerotic plaques and the process of aortic histological changes. Pue reduced IL-6 and TNF-α. HDAC1 expression was down-regulated and p-JNK-1 and JNK protein expression was up-regulated. CONCLUSION: Pue reduces inflammation and alleviates AS induced by acrolein by mediating the JNK pathway to inhibit HDAC1-mediated oxidative stress disorder.
Sujet(s)
Acroléine , Athérosclérose , Histone Deacetylase 1 , Isoflavones , Stress oxydatif , Animaux , Athérosclérose/induit chimiquement , Athérosclérose/métabolisme , Athérosclérose/traitement médicamenteux , Stress oxydatif/effets des médicaments et des substances chimiques , Histone Deacetylase 1/métabolisme , Isoflavones/pharmacologie , Isoflavones/usage thérapeutique , Acroléine/pharmacologie , Mâle , Facteur de nécrose tumorale alpha/métabolisme , Interleukine-6/métabolisme , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Souris , Modèles animaux de maladie humaine , Test ELISA , Technique de Western , Aorte/effets des médicaments et des substances chimiques , Aorte/anatomopathologieRÉSUMÉ
In this study, a novel adsorbent, A-PEI/CS-Cu2+, was developed by crosslinking polyethyleneimine/chitosan hydrogel with acrolein and loading it with copper ions. The adsorption process of A-PEI/CS-Cu2+ on the anionic dye acid yellow 36 (AY36) was investigated by kinetic, isothermal and thermodynamic modeling. It was noteworthy that A-PEI/CS-Cu2+ exhibited rapid adsorption with a 90 % removal rate achieved within just 5 min, which was much faster than the adsorption rate of A-PEI/CS without load of copper ions and showed its potential for rapid adsorption applications. The maximum adsorption capacity for AY36 could reach up to 3114 mg g-1. In addition, the high concentration of saline wastewater was found to have almost no effect on the adsorption reaction in the salt effect test experiment. In five desorption-regeneration cycle experiments, the sample exhibited good recyclability and regeneration performance. The driving force of the adsorption process mainly originated from the electrostatic interaction, hydrogen bonding, and intermolecular interaction, in which the addition of copper ions led to the enhancement of the electrostatic interaction and chelation between A-PEI/CS-Cu2+ and AY36. Overall, the findings suggest the excellent potential of A-PEI/CS-Cu2+ for rapid and efficient adsorption, as well as its suitability for practical applications in wastewater treatment.
Sujet(s)
Acroléine , Chitosane , Cuivre , Hydrogels , Polyéthylèneimine , Polluants chimiques de l'eau , Chitosane/composition chimique , Cuivre/composition chimique , Polyéthylèneimine/composition chimique , Adsorption , Hydrogels/composition chimique , Polluants chimiques de l'eau/composition chimique , Cinétique , Acroléine/composition chimique , Composés azoïques/composition chimique , Thermodynamique , Anions/composition chimique , Purification de l'eau/méthodes , Agents colorants/composition chimique , Eaux usées/composition chimique , Ions/composition chimique , Concentration en ions d'hydrogèneRÉSUMÉ
Sodium alginate (SA) is widely used in the food, biomedical, and chemical industries due to its biocompatibility, biodegradability, and excellent film-forming properties. This article introduces a simple method for preparing uniform alginate-based packaging materials with exceptional properties for fruit preservation. The alginate was uniformly crosslinked by gradually releasing calcium ions triggered by the sustained hydrolysis of gluconolactone (GDL). A cinnamaldehyde (CA) emulsion, stabilized by xanthan without the use of traditional surfactants, was tightly incorporated into the alginate film to enhance its antimicrobial, antioxidant, and UV shielding properties. The alginate-based film effectively blocked ultraviolet rays in the range of 400-200 nm, while allowing for a visible light transmittance of up to 70 %. Additionally, it showed an increased water contact angle and decreased water vapor permeability. The alginate-based film was also employed in the preparation of coated paper through the commonly used coating process in the papermaking industry. The alginate-based material displayed excellent antioxidant properties and antimicrobial activity against Escherichia coli, Staphylococcus aureus and Botrytis cinerea, successfully extending the shelf life of strawberries to 7 days at room temperature. This low-cost and facile method has the potential to drive advancements in the food and biomedical fields by tightly incorporating active oil onto a wide range of biomacromolecule substrates.
Sujet(s)
Acroléine , Alginates , Antioxydants , Fruit , Alginates/composition chimique , Fruit/composition chimique , Acroléine/analogues et dérivés , Acroléine/composition chimique , Acroléine/pharmacologie , Antioxydants/pharmacologie , Antioxydants/composition chimique , Conservation aliments/méthodes , Emballage alimentaire/méthodes , Anti-infectieux/pharmacologie , Anti-infectieux/composition chimique , Escherichia coli/effets des médicaments et des substances chimiquesRÉSUMÉ
Most reported breast cancer-associated deaths are directly correlated with metastatic disease. Additionally, the primary goal of treating metastatic breast cancer is to prolong life. Thus, there remains the need for more effective and safer strategies to treat metastatic breast cancer. Recently, more attention has been given to natural products (or phytochemicals) as potential anticancer treatments. This study aimed to investigate the synergistic effects of the combination of the phytochemicals chlorogenic acid and cinnamaldehyde (CGA and CA) toward inhibiting metastasis. The hypothesis was that CGA and CA in combination decrease the metastatic potential of breast cancer cells by inhibiting their invasive and migratory abilities as well as the induction of apoptosis via the downregulation of the Akt, disrupting its signal transduction pathway. To test this, wound-healing and Transwell™ Matrigel™ assays were conducted to assess changes in the migration and invasion properties of the cells; apoptosis was analyzed by fluorescence microscopy for Annexin V/propidium iodide; and immunoblotting and FACSort were performed on markers for the epithelial-to-mesenchymal transition status. The results show that CGA and CA significantly downregulated Akt activation by inhibiting phosphorylation. Consequently, increased caspase 3 and decreased Bcl2-α levels were observed, and apoptosis was confirmed. The inhibition of metastatic behavior was demonstrated by the attenuation of N-cadherin, fibronectin, vimentin, and MMP-9 expressions with concomitant increased expressions of E-cadherin and EpCAM. In summary, the present study demonstrated that CGA and CA in combination downregulated Akt activation, inhibited the metastatic potential, and induced apoptosis in different breast cancer cell lines.
Sujet(s)
Acroléine , Apoptose , Tumeurs du sein , Mouvement cellulaire , Acide chlorogénique , Protéines proto-oncogènes c-akt , Humains , Acide chlorogénique/pharmacologie , Protéines proto-oncogènes c-akt/métabolisme , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Tumeurs du sein/anatomopathologie , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Femelle , Mouvement cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Régulation négative/effets des médicaments et des substances chimiques , Transition épithélio-mésenchymateuse/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Métastase tumoraleRÉSUMÉ
Inflammatory bowel disease (IBD) comprises a group of idiopathic intestinal disorders, including ulcerative colitis and Crohn's disease, significantly impacting the quality of life for affected individuals. The effective management of these conditions remains a persistent challenge. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, a complex molecular structure, regulates the production of pro-inflammatory cytokines such as interleukin-1ß. Abnormal activation of the NLRP3 inflammasome plays a pivotal role in the development of IBD, making it a compelling target for therapeutic intervention. Our research revealed that cinnamaldehyde (CA), a major bioactive compound found in the leaves of Cinnamomum osmophloeum kaneh, demonstrated a remarkable ability to alleviate colitis induced by dextran sulfate sodium (DSS) in a mouse model. This effect was attributed to CA's ability to downregulate the activation of the NLRP3 inflammasome and reduce the expression of pro-inflammatory mediators in the colon. In the mechanism study, we observed that CA inhibited the NLRP3 inflammasome in macrophages, at least partially, by enhancing the autophagic response, without reducing mitochondrial damage. These findings collectively suggest that CA holds significant potential as a therapeutic agent for enhancing the management of IBD, offering a promising avenue for further research and development.
Sujet(s)
Acroléine , Cinnamomum , Colite , Sulfate dextran , Inflammasomes , Souris de lignée C57BL , Protéine-3 de la famille des NLR contenant un domaine pyrine , Feuilles de plante , Animaux , Acroléine/analogues et dérivés , Acroléine/pharmacologie , Protéine-3 de la famille des NLR contenant un domaine pyrine/métabolisme , Protéine-3 de la famille des NLR contenant un domaine pyrine/antagonistes et inhibiteurs , Souris , Colite/induit chimiquement , Colite/traitement médicamenteux , Cinnamomum/composition chimique , Inflammasomes/effets des médicaments et des substances chimiques , Inflammasomes/métabolisme , Feuilles de plante/composition chimique , MâleRÉSUMÉ
Acrolein (ACR), an unsaturated, highly reactive aldehyde, is a widespread environmental toxin. ACR exerts permanent and irreversible side effects on ovarian functions. Granulosa cells play a crucial role in supporting ovarian function. Thus, in this study, we investigated the toxicity effects of granulosa cells induced by ACR. Following treatment with varying ACR concentrations (0, 12.5, 25, 50, and 100⯵M), we observed that ACR exposure induced reactive oxygen species accumulation, mitochondrial energy metabolism disorder, and apoptosis in KGN cells (a human ovarian granulosa cell line) in a dose-dependent manner. In addition, mitochondrial biogenesis in KGN cells displayed biphasic changes after ACR exposure, with activation at a low ACR dose (12.5⯵M), but inhibition at higher ACR doses (≥50⯵M). SIRT1/PGC-1α-mediated mitochondrial biogenesis is crucial for maintaining intracellular mitochondrial homeostasis and cellular function. The inhibition/activation of the SIRT1/PGC-1α pathway in KGN cells validated its role in ACR-induced damage. The results indicated that the inhibition of the SIRT1/PGC-1α pathway aggravated ACR-induced cell damage, whereas its activation partially counteracted ACR-induced cell damage. This study attempted to uncover a novel mechanism of ACR-induced ovarian toxicity so as to provide an effective treatment option for safeguarding female reproductive health from the adverse effects of ACR.
Sujet(s)
Acroléine , Apoptose , Métabolisme énergétique , Cellules de la granulosa , Mitochondries , Espèces réactives de l'oxygène , Sirtuine-1 , Cellules de la granulosa/effets des médicaments et des substances chimiques , Cellules de la granulosa/métabolisme , Femelle , Humains , Apoptose/effets des médicaments et des substances chimiques , Acroléine/toxicité , Métabolisme énergétique/effets des médicaments et des substances chimiques , Sirtuine-1/métabolisme , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Espèces réactives de l'oxygène/métabolisme , Lignée cellulaire , Coactivateur 1-alpha du récepteur gamma activé par les proliférateurs de peroxysomes/métabolisme , Relation dose-effet des médicamentsRÉSUMÉ
The efficacy of DNA-damaging agents, such as the topoisomerase I inhibitor SN38, is often compromised by the robust DNA repair mechanisms in tumor cells, notably homologous recombination (HR) repair. Addressing this challenge, we introduce a novel nano-strategy utilizing binary tumor-killing mechanisms to enhance the therapeutic impact of DNA damage and mitochondrial dysfunction in cancer treatment. Our approach employs a synergistic drug pair comprising SN38 and the BET inhibitor JQ-1. We synthesized two prodrugs by conjugating linoleic acid (LA) to SN38 and JQ-1 via a cinnamaldehyde thioacetal (CT) bond, facilitating co-delivery. These prodrugs co-assemble into a nanostructure, referred to as SJNP, in an optimal synergistic ratio. SJNP was validated for its efficacy at both the cellular and tissue levels, where it primarily disrupts the transcription factor protein BRD4. This disruption leads to downregulation of BRCA1 and RAD51, impairing the HR process and exacerbating DNA damage. Additionally, SJNP releases cinnamaldehyde (CA) upon CT linkage cleavage, elevating intracellular ROS levels in a self-amplifying manner and inducing ROS-mediated mitochondrial dysfunction. Our results indicate that SJNP effectively targets murine triple-negative breast cancer (TNBC) with minimal adverse toxicity, showcasing its potential as a formidable opponent in the fight against cancer.
Sujet(s)
Acroléine , Camptothécine , Systèmes de délivrance de médicaments , Nanoparticules , Tumeurs du sein triple-négatives , Tumeurs du sein triple-négatives/traitement médicamenteux , Nanoparticules/administration et posologie , Nanoparticules/composition chimique , Animaux , Humains , Femelle , Lignée cellulaire tumorale , Acroléine/analogues et dérivés , Acroléine/administration et posologie , Acroléine/composition chimique , Camptothécine/analogues et dérivés , Camptothécine/administration et posologie , Camptothécine/usage thérapeutique , Camptothécine/pharmacologie , Promédicaments/administration et posologie , Promédicaments/usage thérapeutique , Acide linoléique/composition chimique , Acide linoléique/administration et posologie , Triazoles/administration et posologie , Triazoles/pharmacologie , Triazoles/composition chimique , Altération de l'ADN/effets des médicaments et des substances chimiques , Antinéoplasiques/administration et posologie , Antinéoplasiques/usage thérapeutique , Antinéoplasiques/pharmacologie , Souris nude , Souris , Protéines du cycle cellulaire/métabolisme , Facteurs de transcription/métabolisme , Inhibiteurs de la topoisomérase-I/administration et posologie , Protéines contenant un bromodomaine , AzépinesRÉSUMÉ
BACKGROUND: Malassezia globosa is a commensal basidiomycetous yeast occurring on the skin that causes pityriasis versicolor (PV) and seborrheic dermatitis, but that has also been implicated in other dermatoses. Cinnamaldehyde (CM) has antibacterial, antioxidant, and anti-inflammatory activities, but the effect of CM on M. globosa-infected PV has not been clarified. PURPOSE: The study aimed to investigate the possible antifungal and antibiofilm activities of CM against M. globosa-infected PV in vivo and in vitro. METHODS: The broth microdilution method was used to determine the minimum inhibitory concentration (MIC) of CM against M. globosa. The crystal violet staining assay and XTT assay were used to investigate the inhibition of CM on biofilm formation and the eradication of mature biofilms. The visualizations of the biofilm and cell distribution in the biofilm matrix were performed with a scanning electron microscope and confocal laser scanning microscope. The kits of antioxidant kinase were used to determine the activities of oxidative stress markers in M. globosa-stimulated HaCaT cells. Western blot assays were used to evaluate the role of TLR2/NF-κB in vitro. Furthermore, the protective effect of CM was assessed in M. globosa-associated PV mice. The expressions of inflammatory cytokines and apoptosis were screened using ELISA assays. The expressions of interleukin-6 and tumor necrosis factor-α were measured by an immunohistochemistry method in vivo. RESULTS: Our results showed that the MIC of CM against planktonic cells of M. globosa was 4 µg/ml and treatment with 20 × MIC CM eradicated mature biofilms of M. globosa. In vitro, after CM treatment the levels of oxidative stress indicators (i.e., superoxide dismutase, catalase, glutathione) significantly increased, while the levels of malondialdehyde decreased. In addition, the expression of TLR2/NF-κB in HaCaT cells was significantly reduced after CM treatment. On the other hand, an in vivo therapeutic effect of CM was assessed against M. globosa-infected mice. The fungal load on the skin decreased after treatment with CM compared to the M. globosa-infected group. In addition, the uninfected animals showed a normal skin structure, whereas, the M. globosa-infected mice showed extensive infiltration of neutrophils in skin tissues that improved after treatment with CM. Meanwhile, the levels of inflammatory and apoptotic factors improved after CM treatment. CONCLUSION: Our results showed that CM inhibits the biofilm formation of M. globosa and eradicates mature biofilms of M. globosa. Treatment with CM significantly decreased oxidative stress, apoptosis, and inflammatory markers in the skin tissue and HaCaT cells. Hence, this study suggests that CM is a good candidate therapeutic agent against M. globosa-induced PV infections because of its antifungal, antibiofilm, and anti-inflammatory properties.